Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone vs sulfonylurea added to metformin for cardiovascular outcomes in type 2 diabetes
2008-000738-39Phase 4Active
- Sponsor
- Società Italiana di Diabetologia
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of pioglitazone in type 2 diabetes mellitus (T2DM) and cardiac morbidity (2 arms), sponsored by Società Italiana di Diabetologia. Primary endpoint: Composite major cardiovascular events. Started Jul 2008; status: active.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)cardiac morbidity
Beyond the preview
Go deeper on 2008-000738-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000738-39.